Skip to main content
Article
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence
Nature Medicine (2017)
  • Jian Yuan Goh, Genome Institute of Singapore
  • Min Feng, Genome Institute of Singapore
  • Wenyu Wang, Genome Institute of Singapore
  • Gokce Oguz, Genome Institute of Singapore
  • Gokce Oguz, National University of Singapore
  • Siti Maryam J M Yatim, Genome Institute of Singapore
  • Puay Leng Lee, Genome Institute of Singapore
  • Yi Bao, Genome Institute of Singapore
  • Tse Hui Lim, Singapore General Hospital
  • Panpan Wang, Jinan University
  • Wai Leong Tam, Genome Institute of Singapore
  • Wai Leong Tam, National University of Singapore
  • Annette R Kodahl, Oncology
  • Maria B Lyng, Department of Cancer and Inflammation Research
  • Suman Sarma, Genome Institute of Singapore
  • Selena Y Lin, John Wayne Cancer Institute
  • Alexander Lezhava, Genome Institute of Singapore
  • Yoon Sim Yap, National Cancer Centre Singapore
  • Alvin S T Lim, Singapore General Hospital
  • Dave S B Hoon
  • Henrik J Ditzel, Ditzel group
  • Soo Chin Lee, National University of Singapore
  • Soo Chin Lee, University Health System
  • Ern Yu Tan, Agency for Science, Technology and Research
  • Ern Yu Tan, Tan Tock Seng Hospital
  • Qiang Yu, Duke–NUS Medical School
Disciplines
Publication Date
November 1, 2017
DOI
10.1038/nm.4405
Citation Information
Jian Yuan Goh, Min Feng, Wenyu Wang, Gokce Oguz, et al.. "Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence" Nature Medicine Vol. 23 Iss. 11 (2017) p. 1319 - 1330
Available at: http://works.bepress.com/dave-hoon/46/